Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114951) titled 'Clinical and Pathological Characteristics and Treatment Outcomes of SMARCA4-Deficient Non-Small Cell Lung Cancer: A Dual-Center Retrospective Analysis' on Dec. 19, 2025.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Yuebei People's Hospital
Condition:
SMARCA4-Deficient Non-Small Cell Lung Cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-19
Target Sample Size: Observation group:300;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=301548
Published by HT Digital Content Services with p...